(VIANEWS) – The NASDAQ ended the session with Viking Therapeutics rising 4.25% to $2.58 on Wednesday, after four successive sessions in a row of gains. NASDAQ fell 0.15% to $11,053.08, after two consecutive sessions in a row of gains, on what was a somewhat negative trend exchanging session today.
Today’s last reported volume for Viking Therapeutics is 912696, 1.31% above its average volume of 900829.
Viking Therapeutics’s last close was $2.47, 75.52% below its 52-week high of $10.09.
The company’s growth estimates for the present quarter and the next is a negative 61.5% and a negative 46.7%, respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Viking Therapeutics’s stock is considered to be oversold (<=20).
Viking Therapeutics’s Stock Yearly Top and Bottom Value
Viking Therapeutics’s stock is valued at $2.58 at 18:39 EST, way under its 52-week low of $4.81.
Viking Therapeutics’s Moving Average
Viking Therapeutics’s value is way under its 50-day moving average of $5.82 and way below its 200-day moving average of $6.03.
More news about Viking Therapeutics (VKTX).